| Financial Year |
March 31 2022 |
| Monetary Funds |
9,857,290,660.38 |
| Held-for-trading Financial Assets |
80,000,000.00 |
| Notes Receivable |
1,103,458,020.89 |
| Accounts Receivable |
1,997,274,968.20 |
| Advances to Suppliers |
370,618,108.46 |
| Other Receivables |
249,816,181.85 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,022,751,251.82 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
514,095,695.74 |
| Total Current Assets |
15,623,196,531.67 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
6,807,776,526.53 |
| Investment Properties |
26,898,062.29 |
| Fixed Assetes |
15,946,920,426.30 |
| Under-construction Projects |
2,736,113,839.31 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
5,910,583,421.43 |
| R&D expenses |
-- |
| Goodwill |
164,367,338.81 |
| Long-Term Deferred and Prepaid Expenses |
11,368,308.83 |
| Deferred Income Tax Assets |
350,596,253.28 |
| Other Non-Current Assets |
425,188,479.36 |
| Sub-Total of Non-Current Assets |
33,900,193,583.40 |
| Total Assets |
49,523,390,115.07 |
| Short-Term Loans |
11,083,675,785.74 |
| Trading Financial liabilities |
176,457,161.30 |
| Notes Payable |
332,676,602.52 |
| Accounts Payable |
3,730,428,867.24 |
| Accounts Received In Advance |
22,794,000.00 |
| Employee Compensation Payable |
794,989,720.85 |
| Taxes Payable |
1,058,166,005.91 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
967,682,889.47 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,498,704,710.64 |
| Other Current Liabilities |
170,410,778.01 |
| Sub-Total of Current Liabilities |
21,175,193,949.92 |
| Long-term Loans |
67,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
123,816,181.97 |
| Special Payable |
-- |
| Estimatied Liabilities |
648,547,762.06 |
| Deferred Income Tax Liabilities |
630,128,497.90 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,576,190,667.47 |
| Total Liabilities |
23,751,384,617.39 |
| Paid-In Capital(Or Share Stock) |
3,533,546,850.00 |
| Capital Surplus |
4,120,339,525.42 |
| Surplus Reserve |
2,351,619,569.34 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
12,035,527,773.47 |
| Minority Stockholder's Interest |
3,876,463,313.11 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
21,895,542,184.57 |
| Owner's Equity（Stockholder's Equity） |
25,772,005,497.68 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
49,523,390,115.07 |
